These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20464875)

  • 1. [Quo vadis phytotherapy? Guidelines in the EU are being established].
    Beer AM
    MMW Fortschr Med; 2010 Apr; 152(16):32. PubMed ID: 20464875
    [No Abstract]   [Full Text] [Related]  

  • 2. European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP).
    Zoccali C; Abramowicz D; Cannata-Andia JB; Cochat P; Covic A; Eckardt KU; Fouque D; Heimburger O; McLeod A; Lindley E; Locatelli F; Spasovski G; Tattersall J; Van Biesen W; Wanner C; Vanholder R; ;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2162-6. PubMed ID: 18469309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines in healthcare: the experience of the Prestige project.
    Gordon C; Veloso M
    Stud Health Technol Inform; 1999; 68():733-8. PubMed ID: 10724991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The European Code Against Injuries (ECAI): translating evidence into practice.
    Petridou ET; Germeni E
    Inj Prev; 2008 Oct; 14(5):282-3. PubMed ID: 18836042
    [No Abstract]   [Full Text] [Related]  

  • 5. [New guidelines put their faith in European standards. Not rigid instruction but guiding principle].
    Aumiller J
    MMW Fortschr Med; 2006 Feb; 148(7):41, 43-4. PubMed ID: 16529362
    [No Abstract]   [Full Text] [Related]  

  • 6. Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries.
    Reimer J; Schulte B; Castells X; Schafer I; Polywka S; Hedrich D; Wiessing L; Haasen C; Backmund M; Krausz M
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S373-8. PubMed ID: 15768351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role].
    Ainsworth MA
    Ugeskr Laeger; 2003 Apr; 165(16):1648-9. PubMed ID: 12756819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Registration of new medicinal products in Europe].
    Singer E
    Onkologie; 2008; 31 Suppl 2():64-6. PubMed ID: 18487872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Presentation: European practice guidelines for the prevention of cardiovascular diseases in clinical practice].
    Di Pasquale G
    G Ital Cardiol (Rome); 2008 Jan; 9(1):9-10. PubMed ID: 18383762
    [No Abstract]   [Full Text] [Related]  

  • 10. [New guidelines of the European Union. Motivation for drug testing in pediatrics].
    Appel K
    Dtsch Med Wochenschr; 2001 May; 126(18):A403. PubMed ID: 11381643
    [No Abstract]   [Full Text] [Related]  

  • 11. To which extent should potency choice in homeopathy be "regulated": has European legislation gone too far?
    van Haselen R
    Wien Med Wochenschr; 2005 Nov; 155(21-22):479-81. PubMed ID: 16425107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New evaluation by the EU approval committee. Benefits of cox-2 inhibitors outweigh possible risks (interview by Dr. Thomas Meissner)].
    Brune K
    MMW Fortschr Med; 2004 Feb; 146(9):47. PubMed ID: 15352709
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug research and its international harmonization].
    Idänpään-Heikkilä JE
    Duodecim; 1998; 114(10):951, 953-4. PubMed ID: 11524783
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug development for children: how adequate is the current European ethical guidance?
    Westra AE; Engberts DP; Sukhai RN; Wit JM; de Beaufort ID
    Arch Dis Child; 2010 Jan; 95(1):3-6. PubMed ID: 19321505
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
    Rose M; Zielen S
    Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increased commercial financing of national Medical Product Agencies within the EU].
    Ramel B
    Lakartidningen; 2003 Jan; 100(5):338-9. PubMed ID: 12607381
    [No Abstract]   [Full Text] [Related]  

  • 17. Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project.
    Bentzen SM; Heeren G; Cottier B; Slotman B; Glimelius B; Lievens Y; van den Bogaert W
    Radiother Oncol; 2005 Jun; 75(3):355-65. PubMed ID: 16086915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review, critique, and guidelines for the use of herbs and homeopathy.
    Franklin P
    J Child Fam Nurs; 1999; 2(6):418-9. PubMed ID: 10847026
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug evaluation and approval process in the European Union.
    San Miguel MT; Vargas E
    Arthritis Rheum; 2006 Feb; 55(1):12-4. PubMed ID: 16463405
    [No Abstract]   [Full Text] [Related]  

  • 20. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.